212 related articles for article (PubMed ID: 33638217)
1. Across-species meta-analysis of dexamethasone pharmacokinetics utilizing allometric and scaling modeling approaches.
Song D; Jusko WJ
Biopharm Drug Dispos; 2021 May; 42(5):191-203. PubMed ID: 33638217
[TBL] [Abstract][Full Text] [Related]
2. Meta-Assessment of Metformin Absorption and Disposition Pharmacokinetics in Nine Species.
Jeong YS; Jusko WJ
Pharmaceuticals (Basel); 2021 Jun; 14(6):. PubMed ID: 34200427
[TBL] [Abstract][Full Text] [Related]
3. Across-Species Scaling of Monoclonal Antibody Pharmacokinetics Using a Minimal PBPK Model.
Zhao J; Cao Y; Jusko WJ
Pharm Res; 2015 Oct; 32(10):3269-81. PubMed ID: 25939552
[TBL] [Abstract][Full Text] [Related]
4. Physiologically Based Pharmacokinetics of Dexamethasone in Rats.
Song D; Sun L; DuBois DC; Almon RR; Meng S; Jusko WJ
Drug Metab Dispos; 2020 Sep; 48(9):811-818. PubMed ID: 32601175
[TBL] [Abstract][Full Text] [Related]
5. Minimal physiologically-based pharmacokinetic modeling of DSTA4637A, A novel THIOMAB™ antibody antibiotic conjugate against Staphylococcus aureus, in a mouse model.
Wang-Lin SX; Zhou C; Kamath AV; Hong K; Koppada N; Saad OM; Carrasco-Triguero M; Khojasteh C; Deng R
MAbs; 2018 Oct; 10(7):1131-1143. PubMed ID: 30081725
[TBL] [Abstract][Full Text] [Related]
6. Modeling and allometric scaling of s(+)-ketoprofen pharmacokinetics and pharmacodynamics: a retrospective analysis.
Lepist EI; Jusko WJ
J Vet Pharmacol Ther; 2004 Aug; 27(4):211-8. PubMed ID: 15305849
[TBL] [Abstract][Full Text] [Related]
7. Time-dependent pharmacokinetics of dexamethasone and its efficacy in human breast cancer xenograft mice: a semi-mechanism-based pharmacokinetic/pharmacodynamic model.
Li J; Chen R; Yao QY; Liu SJ; Tian XY; Hao CY; Lu W; Zhou TY
Acta Pharmacol Sin; 2018 Mar; 39(3):472-481. PubMed ID: 29119968
[TBL] [Abstract][Full Text] [Related]
8. Allometric scaling of pegylated liposomal anticancer drugs.
Caron WP; Clewell H; Dedrick R; Ramanathan RK; Davis WL; Yu N; Tonda M; Schellens JH; Beijnen JH; Zamboni WC
J Pharmacokinet Pharmacodyn; 2011 Oct; 38(5):653-69. PubMed ID: 21863380
[TBL] [Abstract][Full Text] [Related]
9. Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: what have we learned?
Deng R; Iyer S; Theil FP; Mortensen DL; Fielder PJ; Prabhu S
MAbs; 2011; 3(1):61-6. PubMed ID: 20962582
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Human Pharmacokinetics of E0703, a Novel Radioprotective Agent, Using Physiologically Based Pharmacokinetic Modeling and an Interspecies Extrapolation Approach.
Ge YX; Zhang Z; Yan JY; Ma ZC; Wang YG; Xiao CR; Zhuang XM; Gao Y
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474292
[TBL] [Abstract][Full Text] [Related]
11. Allometric pharmacokinetic scaling: towards the prediction of human oral pharmacokinetics.
Feng MR; Lou X; Brown RR; Hutchaleelaha A
Pharm Res; 2000 Apr; 17(4):410-8. PubMed ID: 10870984
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacodynamic modeling of intramuscular and oral dexamethasone and betamethasone effects on six biomarkers with circadian complexities in Indian women.
Krzyzanski W; Milad MA; Jobe AH; Peppard T; Bies RR; Jusko WJ
J Pharmacokinet Pharmacodyn; 2021 Jun; 48(3):411-438. PubMed ID: 33954911
[TBL] [Abstract][Full Text] [Related]
13. Interspecies allometric meta-analysis of the comparative pharmacokinetics of 85 drugs across veterinary and laboratory animal species.
Huang Q; Gehring R; Tell LA; Li M; Riviere JE
J Vet Pharmacol Ther; 2015 Jun; 38(3):214-26. PubMed ID: 25333341
[TBL] [Abstract][Full Text] [Related]
14. Minimal Physiologically Based Pharmacokinetic-Pharmacodynamic (mPBPK-PD) Model of
Ayyar VS; Song D; Zheng S; Carpenter T; Heald DL
J Pharmacol Exp Ther; 2021 Nov; 379(2):134-146. PubMed ID: 34413198
[TBL] [Abstract][Full Text] [Related]
15. Physiologically based pharmacokinetic (PBPK) modeling of disposition of epiroprim in humans.
Luttringer O; Theil FP; Poulin P; Schmitt-Hoffmann AH; Guentert TW; Lavé T
J Pharm Sci; 2003 Oct; 92(10):1990-2007. PubMed ID: 14502539
[TBL] [Abstract][Full Text] [Related]
16. Applications of minimal physiologically-based pharmacokinetic models.
Cao Y; Jusko WJ
J Pharmacokinet Pharmacodyn; 2012 Dec; 39(6):711-23. PubMed ID: 23179857
[TBL] [Abstract][Full Text] [Related]
17. Towards a better prediction of peak concentration, volume of distribution and half-life after oral drug administration in man, using allometry.
Sinha VK; Vaarties K; De Buck SS; Fenu LA; Nijsen M; Gilissen RA; Sanderson W; Van Uytsel K; Hoeben E; Van Peer A; Mackie CE; Smit JW
Clin Pharmacokinet; 2011 May; 50(5):307-18. PubMed ID: 21456631
[TBL] [Abstract][Full Text] [Related]
18. Modelling concentrations of antimicrobial drugs: comparative pharmacokinetics of cephalosporin antimicrobials and accuracy of allometric scaling in food-producing and companion animals.
Taverne FJ; van Geijlswijk IM; Heederik DJ; Wagenaar JA; Mouton JW
BMC Vet Res; 2016 Sep; 12(1):185. PubMed ID: 27596044
[TBL] [Abstract][Full Text] [Related]
19. Minimal physiologically-based hybrid model of pharmacokinetics in pregnant women: Application to antenatal corticosteroids.
Krzyzanski W; Milad MA; Jobe AH; Jusko WJ
CPT Pharmacometrics Syst Pharmacol; 2023 May; 12(5):668-680. PubMed ID: 36917704
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Various Approaches to Translate Non-Linear Pharmacokinetics of Monoclonal Antibodies from Cynomolgus Monkey to Human.
Singh R; Moreno M; Stanimirovic D
Eur J Drug Metab Pharmacokinet; 2021 Jul; 46(4):555-567. PubMed ID: 34120326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
